TTR stabilizers: (1) FDA approved (4) off-labelTTR silencers: prevent amyloid formation(2) SQ, risk of thrombocytopenia and glomerulonephritis (3) IV, fewer reported side effects. This evidence concerns the gene TTR and glomerulonephritis.